Government Incentives Continue to Support Growth of Global Micro-RNA Tools Market

Transparency Market Research is a leading provider of the latest market findings in industries such as pharmaceuticals. One of the more recent titles under this industry is “Micro-RNA Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” Key issues surrounding this market are elaborated upon, along with the knowledge of the various segments that are expected to flourish in the near future.

Get Complete Research Brochure PDF For More Information:

Micro-RNA is a small RNA molecule that is non-coding. It is found in plants, animals, and most importantly, in several viruses. Mirco-RNA comprises nearly 22 nucleotides. The viruses that contain micro-RNA usually work in silencing RNA and also in gene expression regulation in a post-transcriptional manner. They are a major genetic component of all types of eukaryotic cells. Research in micro-RNA can lead to advancements in RNA interference drug discovery, which is a core component in the medical fight against incurable diseases such as AIDS.

The global micro-RNA market is a key provider of medical solutions for some of the most serious diseases in the world. The medical utilities of micro-RNA therefore are very high, due to which the global micro-RNA market has enjoyed consistent attention from investors from both governments and private bodies. Many governments have already made liberal investments for the purpose of advancing national micro-RNA studies to achieve medical solutions for currently incurable diseases.

Some of the major technologies in the global micro-RNA market are Micro-RNA inhibitors, qRT-PCR, microarrays, linear amplification, labeling, and purification.

From a geographical perspective, the global micro-RNA market has been dominated by North America so far, in terms of advancements made through research. North America is closely followed by Europe, after which rank Asia Pacific and the Rest of the World respectively. It is Asia Pacific and the Rest of the world that currently provide the best scope of growth in the global micro-RNA market. Many of the nations in these regions are rapidly improving their healthcare industries and managing a better penetration rate of healthcare services. This implies better quality medical care in urban areas, as well as a greater medical outreach to areas that previously fared poorly in healthcare services. As such, there is a great scope of improvement of the micro-RNA market in these regions, more specifically in the nations of Japan, China, India, and Singapore, along with major national markets in Latin America and the Middle East.

Browse Full Report:

The key players in the global micro-RNA market include Senesco Technologies, Inc., Sirnaomics, Inc., Eli Lilly and Co., Novartis International AG, Illumina, Inc., F. Hoffman-La Roche AG, Covance, Inc., Astrazeneca Pharmaceuticals LP, Benitec Biopharma Limited, Agilent Technologies, Tekmira Pharmaceuticals Corporation, and Access Pharmaceuticals.